FDA grants supplemental claims for dairy and beef replacement heifers

Over the past year, cattle producers had the opportunity to harness the therapeutic potential of Pennchlor^® (chlortetracycline Type A medicated article), coupled with the coccidiosis control and performance enhancements offered by Rumensin^® (monensin Type A medicated article) in their starter rations. But now, two new supplemental claims are available for the well-established combination of Pennchlor and Rumensin. These additional claims now extend this combination’s therapeutic advantages for dairy and beef replacement heifers.

At a time when input costs, including feed, are above historic levels, the ability to use these products in combination gives producers more options to improve the sustainability and efficiency of their business.

In addition to their well-established benefits, these additional claims offer a more comprehensive solution for the health and growth of replacement beef and dairy heifers. The combination of Pennchlor and Rumensin effectively treats bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida, provided these pathogens are susceptible to chlortetracycline. Additionally, it promotes an increased rate of weight gain and aids in the prevention and control of coccidiosis due to Eimeria bovis and Eimeria zuernii.

“With these expanded claims, we are not only enhancing animal health but also giving producers more flexibility to adapt their treatment and feed programs and to optimize performance in their dairy and beef replacement heifers,” adds Dr. Padraig Lucey, Elanco dairy technical consultant.

“We are delighted to provide these new claims for dairy and beef replacement heifers. This reflects our unwavering commitment to deliver innovative solutions that empower livestock producers to produce healthier, more productive herds,” says Lisa Wallace, Pharmgate Animal Health marketing manager.

Contact your Elanco or Pharmgate representative for additional information or your cattle veterinarian and/or nutritionist. To access labeling or other forms, go to https://www.pharmgate.com/usa/.

The label contains complete use information, including cautions and warnings. Always read, understand and follow the label and use directions.

Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

Pharmgate Animal Health provides the livestock and poultry industry with a proven portfolio of technically supported, high-quality products that are the foundation of custom herd and flock health protocols. Founded in 2008, the company is headquartered in Wilmington, North Carolina, with FDA-approved pharmaceutical production facilities in Omaha, Nebraska, and vaccine research and manufacturing operations in St. Paul, Minnesota. To learn more about Pharmgate Animal Health, or to find a local representative, visit www.Pharmgate.com/usa.

Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we’re driven by our vision of Food and Companionship Enriching Life and our approach to sustainability, Elanco Healthy Purpose™– all to advance the health of animals, people, the planet and our enterprise. Learn more at www.elanco.com.